Unknown

Dataset Information

0

FLASH X-ray spares intestinal crypts from pyroptosis initiated by cGAS-STING activation upon radioimmunotherapy.


ABSTRACT: DNA-damaging treatments such as radiotherapy (RT) have become promising to improve the efficacy of immune checkpoint inhibitors by enhancing tumor immunogenicity. However, accompanying treatment-related detrimental events in normal tissues have posed a major obstacle to radioimmunotherapy and present new challenges to the dose delivery mode of clinical RT. In the present study, ultrahigh dose rate FLASH X-ray irradiation was applied to counteract the intestinal toxicity in the radioimmunotherapy. In the context of programmed cell death ligand-1 (PD-L1) blockade, FLASH X-ray minimized mouse enteritis by alleviating CD8+ T cell-mediated deleterious immune response compared with conventional dose rate (CONV) irradiation. Mechanistically, FLASH irradiation was less efficient than CONV X-ray in eliciting cytoplasmic double-stranded DNA (dsDNA) and in activating cyclic GMP-AMP synthase (cGAS) in the intestinal crypts, resulting in the suppression of the cascade feedback consisting of CD8+ T cell chemotaxis and gasdermin E-mediated intestinal pyroptosis in the case of PD-L1 blocking. Meanwhile, FLASH X-ray was as competent as CONV RT in boosting the antitumor immune response initiated by cGAS activation and achieved equal tumor control in metastasis burdens when combined with anti-PD-L1 administration. Together, the present study revealed an encouraging protective effect of FLASH X-ray upon the normal tissue without compromising the systemic antitumor response when combined with immunological checkpoint inhibitors, providing the rationale for testing this combination as a clinical application in radioimmunotherapy.

SUBMITTER: Shi X 

PROVIDER: S-EPMC9618056 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

FLASH X-ray spares intestinal crypts from pyroptosis initiated by cGAS-STING activation upon radioimmunotherapy.

Shi Xiaolin X   Yang Yiwei Y   Zhang Wei W   Wang Jianxin J   Xiao Dexin D   Ren Huangge H   Wang Tingting T   Gao Feng F   Liu Zhen Z   Zhou Kui K   Li Peng P   Zhou Zheng Z   Zhang Peng P   Shen Xuming X   Liu Yu Y   Zhao Jianheng J   Wang Zhongmin Z   Liu Fenju F   Shao Chunlin C   Wu Dai D   Zhang Haowen H  

Proceedings of the National Academy of Sciences of the United States of America 20221018 43


DNA-damaging treatments such as radiotherapy (RT) have become promising to improve the efficacy of immune checkpoint inhibitors by enhancing tumor immunogenicity. However, accompanying treatment-related detrimental events in normal tissues have posed a major obstacle to radioimmunotherapy and present new challenges to the dose delivery mode of clinical RT. In the present study, ultrahigh dose rate FLASH X-ray irradiation was applied to counteract the intestinal toxicity in the radioimmunotherapy  ...[more]

Similar Datasets

| S-EPMC8188492 | biostudies-literature
| S-EPMC11657496 | biostudies-literature
| S-EPMC10918897 | biostudies-literature
| S-EPMC11300882 | biostudies-literature
| S-EPMC8894389 | biostudies-literature
| S-EPMC9188164 | biostudies-literature
| S-EPMC7472700 | biostudies-literature
| S-EPMC8971356 | biostudies-literature
| S-EPMC11388346 | biostudies-literature
| S-EPMC7368095 | biostudies-literature